Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations
Giovanna Gallo,1 Massimo Volpe,1 Speranza Rubattu1,2 1Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant’Andrea Hospital, Rome, Italy; 2IRCCS Neuromed, Pozzilli, IS, ItalyCorrespondence: Speranza Rubattu, Department of Clinical and Molecular Medicine, Sapienza Universit...
Main Authors: | Gallo G, Volpe M, Rubattu S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-07-01
|
Series: | Vascular Health and Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/angiotensin-receptor-blockers-in-the-management-of-hypertension-a-real-peer-reviewed-fulltext-article-VHRM |
Similar Items
-
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19
by: Emilia Roy-Vallejo, et al.
Published: (2021-06-01) -
Influence of Renin-Angiotensin System Inhibitors on Postoperative Delirium in Patients With Pulmonary Arterial Hypertension: A Secondary Analysis of a Retrospective Cohort Study
by: Gong Chen, et al.
Published: (2022-04-01) -
Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study
by: Nhi Thi Hong Nguyen, et al.
Published: (2023-02-01) -
The use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may relate to the survival and walking ability in geriatric patients with hip fractures: a 1-year follow-up study
by: Qining Chu, et al.
Published: (2023-03-01) -
Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study
by: Po-Chih Li, et al.
Published: (2022-04-01)